Premium
KIR3DL2 MUTATION MAY DEFINE A HIGH RATE OF RESPONSE OF AITL TO TIPIFARNIB
Author(s) -
Gualberto A.,
Scholz C.,
Mishra V.,
Kessler L.,
Rodriguez M.,
Piris M.,
Witzig T.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.20_2630
Subject(s) - mutation , cancer research , medicine , genetics , biology , gene